[1]
Ownis, A. 2026. CRISPR-dCas9-Mediated Epigenetic Reactivation of LRIG1 Suppresses Oncogenic Signaling in Triple-Negative Breast Cancer. Academy Journal for Basic and Applied Sciences. 8, 1 (Jan. 2026). DOI:https://doi.org/10.5281/zenodo.20367830.